Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pomalidomide, quantity: 2 mg - capsule, hard - excipient ingredients: croscarmellose sodium; mannitol; sodium stearylfumarate; pregelatinised starch; titanium dioxide; indigo carmine; purified water; iron oxide yellow; erythrosine; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - pomalidomide, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior treatment regimen including lenalidomide.,pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pomalidomide, quantity: 1 mg - capsule, hard - excipient ingredients: pregelatinised starch; croscarmellose sodium; mannitol; sodium stearylfumarate; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute; ammonia - pomalidomide, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior treatment regimen including lenalidomide.,pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pomalidomide, quantity: 4 mg - capsule, hard - excipient ingredients: pregelatinised starch; mannitol; sodium stearylfumarate; croscarmellose sodium; titanium dioxide; indigo carmine; purified water; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - pomalidomide, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior treatment regimen including lenalidomide.,pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - paracetamol, quantity: 500 mg - tablet, gelatin coated - excipient ingredients: sodium lauryl sulfate; starch; gelatin; sodium starch glycollate; magnesium stearate; powdered cellulose; pregelatinised starch; hypromellose; propylene glycol; purified water; isopropyl alcohol; iron oxide black; titanium dioxide; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400; brilliant blue fcf; allura red ac; benzyl alcohol; methyl hydroxybenzoate; propyl hydroxybenzoate; butyl hydroxybenzoate; carmellose sodium; sodium calcium edetate; sodium propionate; quinoline yellow - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

Kenya - English - Pharmacy and Poisons Board

b. braun melsungen ag c/o b.braun medical kenya ltd - gelatin polysuccinate 4%w/v - solution for infusion - gelatin polysuccinate 40mg per ml - blood substitutes and plasma protein fractions

Egypt - English - EDA (Egyptian Drug Authority)

arab company for gelatin and pharmaceutical products - soft gelatin capsule - 0.5 mcg

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - capsule, gelatin coated - 10 mg - sotret is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, sotret should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, sotret is indicated only for those female patients who are not pregnant, because sotret can cause severe birth defects (see boxed contraindications and warnings ). a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may continue to improve while off isotretinoin caps

United States - English - NLM (National Library of Medicine)

anazaohealth corporation - gelatin (unii: 2g86qn327l) (gelatin - unii:2g86qn327l) - gelatin 4.5 mg - tc99m sulfur colloid is used in lymphoscintigraphy studies in breast cancer patients, for liver, spleen and bone marrow imaging and gastric transit studies and gastroesophageal reflux.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ain medicare sdn. bhd. - modified fluid gelatin -

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: pharmakon biotec inc.; distributor: mirabell medical corp. - multivitamins , minerals - hard gelatin capsule - formulation each hard gelatin capsule contains: ferrous fumarate-105mg zinc sulphate monohydrate-28mg magnesium sulfate-1.8mg ascorbic acid (vitamin c)-75mg folic acid (vitamin b9)-0.4mcg cyanocobalamin (vitamin b12)-2.8mcg